We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
10 Year Est. Return
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RENX
1251
DELISTED
RELX N.V.
RENX
-105
Closed -$2K
BCR
1252
DELISTED
CR Bard Inc.
BCR
-70
Closed -$22K
DGI
1253
DELISTED
DigitalGlobe Inc.
DGI
-250
Closed -$9K
RHT
1254
DELISTED
Red Hat Inc
RHT
-274
Closed -$30K
BZF
1255
DELISTED
WisdomTree Brazilian Real Strategy Fund
BZF
-22
Closed
BAL
1256
DELISTED
iPath Bloomberg Cotton Subindex Total Return ETN due June 24, 2038
BAL
-7
Closed

Similar funds

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.